Compare TK & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TK | PRCT |
|---|---|---|
| Founded | 1973 | 2009 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1995 | 2021 |
| Metric | TK | PRCT |
|---|---|---|
| Price | $14.70 | $19.89 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $22.25 |
| AVG Volume (30 Days) | 464.7K | ★ 1.3M |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 7.09% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | N/A | $28.32 |
| Revenue Next Year | N/A | $20.48 |
| P/E Ratio | $13.43 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $8.67 | $16.67 |
| 52 Week High | $15.90 | $38.11 |
| Indicator | TK | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 57.00 |
| Support Level | $13.06 | $19.87 |
| Resistance Level | $15.90 | $22.88 |
| Average True Range (ATR) | 0.49 | 1.03 |
| MACD | -0.11 | 0.29 |
| Stochastic Oscillator | 48.47 | 93.10 |
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.